EyePoint (EYPT) Prepaid Assets (2011 - 2026)
EyePoint (EYPT) posted Prepaid Assets of $1.3 million for Q1 2026, down 63.73% sequentially from $3.5 million in Q4 2025, and down 79.5% YoY from $6.2 million in Q1 2025.
Analysis
EyePoint (EYPT) Prepaid Assets (2011 - 2026) Analysis & Trends
EyePoint has reported Prepaid Assets for 16 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 79.5% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 79.5% YoY) and the FY2025 annual result came in at $3.5 million, up 50.28% from the prior year.
- Prepaid Assets slipped to $1.3 million in Q1 2026 per EYPT's latest filing, from $3.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.1 million in Q1 2024 and troughed at $782000.0 in Q4 2022.
- A 5-year average of $5.4 million and a median of $5.9 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets plunged 81.46% in 2022, then jumped 364.83% in 2024.
- Over 5 years, Prepaid Assets stood at $782000.0 in 2022, then jumped by 116.75% to $1.7 million in 2023, then surged by 37.99% to $2.3 million in 2024, then surged by 50.28% to $3.5 million in 2025, then plunged by 63.73% to $1.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.3 million, $3.5 million, and $899000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.38 Mn |
| Mar 31, 2026 | 24.55 Mn |
| Dec 31, 2025 | 20.11 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 6.22 Mn |
| Dec 31, 2024 | 9.48 Mn |
| Sep 30, 2024 | 11.57 Mn |
| Jun 30, 2024 | 9.64 Mn |
| Mar 31, 2024 | 11.09 Mn |
| Dec 31, 2023 | 9.04 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 9.37 Mn |
| Mar 31, 2023 | 9.08 Mn |
| Dec 31, 2022 | 9.86 Mn |
| Sep 30, 2022 | 10.44 Mn |
| Jun 30, 2022 | 8.85 Mn |
| Mar 31, 2022 | 5.92 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | 3.89 Mn |